These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 38315122)

  • 1. Hydroxyhexylitaconic acids as potent IMP-type metallo-β-lactamase inhibitors for controlling carbapenem resistance in
    Wachino J-i; Jin W; Norizuki C; Kimura K; Tsuji M; Kurosaki H; Arakawa Y
    Microbiol Spectr; 2024 Mar; 12(3):e0234423. PubMed ID: 38315122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulfamoyl Heteroarylcarboxylic Acids as Promising Metallo-β-Lactamase Inhibitors for Controlling Bacterial Carbapenem Resistance.
    Wachino JI; Jin W; Kimura K; Kurosaki H; Sato A; Arakawa Y
    mBio; 2020 Mar; 11(2):. PubMed ID: 32184250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restoring carbapenem efficacy: a novel carbapenem companion targeting metallo-β-lactamases in carbapenem-resistant Enterobacterales.
    Ooi N; Lee VE; Chalam-Judge N; Newman R; Wilkinson AJ; Cooper IR; Orr D; Lee S; Savage VJ
    J Antimicrob Chemother; 2021 Jan; 76(2):460-466. PubMed ID: 33152764
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Lomovskaya O; Castanheira M; Lindley J; Rubio-Aparicio D; Nelson K; Tsivkovski R; Sun D; Totrov M; Loutit J; Dudley M
    Antimicrob Agents Chemother; 2023 Nov; 67(11):e0044023. PubMed ID: 37800963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vitro and In Vivo Development of a β-Lactam-Metallo-β-Lactamase Inhibitor: Targeting Carbapenem-Resistant
    Peters BK; Reddy N; Shungube M; Girdhari L; Baijnath S; Mdanda S; Chetty L; Ntombela T; Arumugam T; Bester LA; Singh SD; Chuturgoon A; Arvidsson PI; Maguire GEM; Kruger HG; Naicker T; Govender T
    ACS Infect Dis; 2023 Mar; 9(3):486-496. PubMed ID: 36786013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ZN148 Is a Modular Synthetic Metallo-β-Lactamase Inhibitor That Reverses Carbapenem Resistance in Gram-Negative Pathogens
    Samuelsen Ø; Åstrand OAH; Fröhlich C; Heikal A; Skagseth S; Carlsen TJO; Leiros HS; Bayer A; Schnaars C; Kildahl-Andersen G; Lauksund S; Finke S; Huber S; Gjøen T; Andresen AMS; Økstad OA; Rongved P
    Antimicrob Agents Chemother; 2020 May; 64(6):. PubMed ID: 32179522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Specific Metallo-β-Lactamase Inhibitor ANT2681 Restores Meropenem Activity to Clinically Effective Levels against NDM-Positive
    Zalacain M; Lozano C; Llanos A; Sprynski N; Valmont T; De Piano C; Davies D; Leiris S; Sable C; Ledoux A; Morrissey I; Lemonnier M; Everett M
    Antimicrob Agents Chemother; 2021 May; 65(6):. PubMed ID: 33820763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 4-Amino-2-Sulfanylbenzoic Acid as a Potent Subclass B3 Metallo-β-Lactamase-Specific Inhibitor Applicable for Distinguishing Metallo-β-Lactamase Subclasses.
    Wachino JI; Kanechi R; Nishino E; Mochizuki M; Jin W; Kimura K; Kurosaki H; Arakawa Y
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31405855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1,4,7-Triazacyclononane Restores the Activity of β-Lactam Antibiotics against Metallo-β-Lactamase-Producing
    Somboro AM; Amoako DG; Osei Sekyere J; Kumalo HM; Khan R; Bester LA; Essack SY
    Appl Environ Microbiol; 2019 Feb; 85(3):. PubMed ID: 30478231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small Molecule Carboxylates Inhibit Metallo-β-lactamases and Resensitize Carbapenem-Resistant Bacteria to Meropenem.
    Tehrani KHME; Brüchle NC; Wade N; Mashayekhi V; Pesce D; van Haren MJ; Martin NI
    ACS Infect Dis; 2020 Jun; 6(6):1366-1371. PubMed ID: 32227874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Captopril potentiated meropenem activity against MBL-producing carbapenem-resistant Klebsiella pneumoniae: in vitro and in vivo study.
    Zhao D; Li H; Yue C; Sun K; Dai Y; Zhang H; Liu Y; Gao Y; Li J
    J Inorg Biochem; 2021 May; 218():111381. PubMed ID: 33647540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of aspergillomarasmine A/meropenem combinations with and without avibactam against bacterial strains producing multiple β-lactamases.
    Rotondo CM; Wright GD
    Antimicrob Agents Chemother; 2024 Sep; 68(9):e0027224. PubMed ID: 39133022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of a Novel Metallo-β-Lactamase Inhibitor That Potentiates Meropenem Activity against Carbapenem-Resistant Enterobacteriaceae.
    Everett M; Sprynski N; Coelho A; Castandet J; Bayet M; Bougnon J; Lozano C; Davies DT; Leiris S; Zalacain M; Morrissey I; Magnet S; Holden K; Warn P; De Luca F; Docquier JD; Lemonnier M
    Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29530861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An updated patent review of metallo-β-lactamase inhibitors (2020-2023).
    Denakpo E; Naas T; Iorga BI
    Expert Opin Ther Pat; 2023; 33(7-8):523-538. PubMed ID: 37737836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. H
    Chen F; Bai M; Liu W; Kong H; Zhang T; Yao H; Zhang E; Du J; Qin S
    Eur J Med Chem; 2021 Nov; 224():113702. PubMed ID: 34303873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of β-Lactam Resistance by Aspergillomarasmine A Is Influenced by both the Metallo-β-Lactamase Target and the Antibiotic Partner.
    Rotondo CM; Sychantha D; Koteva K; Wright GD
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31932375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of specific inhibitors on metallo-β-carbapenemases detected in Escherichia coli and Klebsiella pneumoniae isolates.
    Abbas HA; Kadry AA; Shaker GH; Goda RM
    Microb Pathog; 2019 Jul; 132():266-274. PubMed ID: 31096002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probing the Interaction of Aspergillomarasmine A with Metallo-β-lactamases NDM-1, VIM-2, and IMP-7.
    Bergstrom A; Katko A; Adkins Z; Hill J; Cheng Z; Burnett M; Yang H; Aitha M; Mehaffey MR; Brodbelt JS; Tehrani KHME; Martin NI; Bonomo RA; Page RC; Tierney DL; Fast W; Wright GD; Crowder MW
    ACS Infect Dis; 2018 Feb; 4(2):135-145. PubMed ID: 29091730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbapenem Use Is Driving the Evolution of Imipenemase 1 Variants.
    Cheng Z; Bethel CR; Thomas PW; Shurina BA; Alao JP; Thomas CA; Yang K; Marshall SH; Zhang H; Sturgill AM; Kravats AN; Page RC; Fast W; Bonomo RA; Crowder MW
    Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33468463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial Resistance Patterns of Gram-negative Bacteria in an Iranian Referral Pediatric Hospital: A Present Danger of New Delhi Metallo-β- lactamase.
    Mahmoudi S; Pourakbari B; Rostamyan M; Raji H; Sadeghi RH; Mamishi S
    Infect Disord Drug Targets; 2023; 23(6):e180423215994. PubMed ID: 37106518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.